Prof. Dr. Torsten Kuwert



Organisationseinheit


Lehrstuhl für Klinische Nuklearmedizin


Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 6 Go to next page Go to last page

Potemkin, R., Strauch, B., Geisthoff, M., Kuwert, T., Prante, O., & Maschauer, S. (2019). Development of F-18-fluoroglycosylated PSMA ligands with improved kidney clearance behavior. In JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (pp. S114-S115). HOBOKEN: WILEY.
Götz, T.I., Schmidkonz, C., Lang, E.W., Maier, A., Kuwert, T., & Ritt, P. (2019). Factors affecting accuracy of S values and determination of time-integrated activity in clinical Lu-177 dosimetry. Annals of Nuclear Medicine. https://dx.doi.org/10.1007/s12149-019-01365-6
Ellmann, S., Seyler, L., Evers, J., Heinen, H., Bozec, A., Prante, O.,... Bäuerle, T. (2019). Prediction of early metastatic disease in experimental breast cancer bone metastasis by combining PET/CT and MRI parameters to a Model-Averaged Neural Network. Bone, 120, 254-261. https://dx.doi.org/10.1016/j.bone.2018.11.008
Schonau, V., Roth, J., Tascilar, K., Rech, J., Schmidt, D., Kuwert, T.,... Muratore, F. (2019). RESOLUTION OF VASCULAR INFLAMMATION IN PATIENTS WITH GIANT CELL ARTERITIS RECEIVING GLUCOCORTICOIDS, METHOTREXATE OR TOCILIZUMAB TREATMENT-DATA FROM THE ITALIAN/GERMAN RIGA STUDY. In ANNALS OF THE RHEUMATIC DISEASES (pp. 591-591). Madrid, ES: LONDON: BMJ PUBLISHING GROUP.
Tatsch, K., Buchert, R., Bartenstein, P., Barthel, H., Boecker, H., Brust, P.,... Meyer, P.T. (2019). SPECT Studies with the I-123-labeled Dopamine Transporter Ligands FP-CIT (DaTSCAN(TM)) DGN Recommendation for Action (S1 Guideline). Nuklearmedizin-Nuclear Medicine, 58(1), 5-14. https://dx.doi.org/10.1055/a-0807-8137
Schmidkonz, C., Cordes, M., Schmidt, D., Bäuerle, T., Goetz, T.I., Beck, M.,... Ritt, P. (2018). 68Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. https://dx.doi.org/10.1007/s00259-018-4042-z
Schmidkonz, C., Hollweg, C., Beck, M., Reinfelder, J., Götz, T., Sanders, J.,... Ritt, P. (2018). 99m Tc-MIP-1404-SPECT/CT for the detection of PSMA-positive lesions in 225 patients with biochemical recurrence of prostate cancer. Prostate, 78(1), 54-63. https://dx.doi.org/10.1002/pros.23444
Schmidkonz, C., Cordes, M., Beck, M., Goetz, T.I., Schmidt, D., Prante, O.,... Ritt, P. (2018). Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate Cancer. Clinical Nuclear Medicine, 43(8), e250-e258. https://dx.doi.org/10.1097/RLU.0000000000002162
Rutzner, S., Lubgan, D., Wullich, B., Kuehn, R., Kuwert, T., & Fietkau, R. (2018). Salvage external beam radiation therapy of biochemical relapse after radical prostatectomy: Results and potential role of PET/CT. (pp. 149-150).
Boy, C., Poeppel, T., Kotzerke, J., Krause, B.J., Amthauer, H., Baum, R.P.,... Bockisch, A. (2018). Somatostatin receptor PET/CT (SSTR-PET/CT). Nuklearmedizin-Nuclear Medicine, 57(1), 4-17. https://dx.doi.org/10.1055/s-0038-1636560

Zuletzt aktualisiert 2016-05-05 um 05:32